Pharm/Biotech
Resources

Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

Pharm Stocks

FDA Links

FDA Warning Letters

FDA Doc/cGMP

Pharm/Biotech Events

Consultants

Advertiser Info

Newsletter Subscription

Web Links

Suggestions

Site Map
 

 

 

 

Title:  Method for treating AIDS

United States Patent:   6,015,796

Inventors:  Suzuki; Fujio (Galveston, TX); Sasaki; Hidetaka (Galveston, TX); Kobayashi; Makiko (Galveston, TX)

Assignee:  Zeria Pharmaceutical Co., Ltd. (Tokyo, JP); Natsu Maruyama (Tokyo, JP)

Appl. No.:  038041

Filed:  March 11, 1998

Abstract

The present invention relates to a method for treating AIDS, which comprises administering to an HIV-infected patient (a) a composition containing as the primary component a polysaccharide derived from a hot water extract of human-type tubercle bacillus and (b) a nucleoside-type anti-HIV agent. Due to the incorporation of composition (a), the present invention enhances the therapeutic effect of nucleoside-type anti-HIV agents on AIDS.

SUMMARY OF THE INVENTION

The present inventors have conducted careful studies in an attempt to improve the therapeutic effect of nucleoside-type anti-HIV agents on AIDS patients. They have found that the combined use of a hot water extract of human-type tubercle bacillus and a nucleoside-type anti-HIV agent dramatically improves the mortality of AIDS patients as compared with the case in which the anti-HIV agent alone is administered, leading to completion of the invention. The hot water extract of human-type tubercle bacillus is known as an agent which is effective for ameliorating reduced white blood cell count stemming from radiotherapy.

Accordingly, the present invention provides a method for treating AIDS, which comprises administering to an HIV-infected patient (a) a composition containing as the primary component a polysaccharide derived from a hot water extract of human-type tubercle bacillus and (b) a nucleoside-type anti-HIV agent.

The present invention also provides a remedy for AIDS which comprises as active ingredients (a) a composition containing as the primary component a polysaccharide derived from a hot water extract of human-type tubercle bacillus and (b) a nucleoside-type anti-HIV agent.

The present invention further provides an enhancer drug which comprises as an active ingredient (a) a composition containing as the primary component a polysaccharide derived from a hot water extract of human-type tubercle bacillus and which improves therapeutic effect of a nucleoside-type anti-HIV agent on AIDS patients.

The present invention further provides use, as an enhancer drug for improving therapeutic effect of a nucleoside-type anti-HIV agent on AIDS patients, of (a) a composition containing as the primary component a polysaccharide derived from a hot water extract of human-type tubercle bacillus.

The present invention still further provides use, for the manufacture of a remedy for AIDS, of (a) a composition containing as the primary ingredient a polysaccharide derived from a hot water extract of human-type tubercle bacillus and (b) a nucleoside-type anti-HIV agent.

Claim 1 of 19 Claims

1. A method of treating AIDS, comprising administering to an HIV-infected patient an effective amount of

(a) a composition comprising a polysaccharide produced by a hot aqueous solvent extraction of tubercle bacillus, wherein the polysaccharide is comprised of arabinose, mannose and glucose residues, and

(b) a nucleoside anti-HIV agent.

 

____________________________________________
If you want to learn more about this patent, please go directly to the U.S. Patent and Trademark Office Web site to access the full patent.

 

 

[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ]
[ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ]
[ Site Map ]